Medtronic plc (MDT) operating KPIs
MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 19/303% below fair value
$96.54−0.57 (-0.59%)
Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%
Medtronic acquisition Contingent Consideration Liabilities ($M) ($M)
Annual figures from Medtronic's filings and investor materials
Latest, FY2025
81
Period ended Apr 30, 2025
Change on a year earlier
-45.6%
149 in FY2024
History
6 years
Since FY2020
Sources
5
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Acquisition Contingent Consideration Liabilities ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Apr 30, 2025 | 81 | -45.6% | Medtronic FY2025 Irish Statutory Financial Statements ↗ |
| FY2024 | Apr 30, 2024 | 149 | -27.7% | Medtronic FY2025 Irish Statutory Financial Statements ↗ |
| FY2023 | Apr 30, 2023 | 206 | +73.1% | Medtronic FY2024 Irish Statutory Financial Statements ↗ |
| FY2022 | Apr 30, 2022 | 119 | -55.9% | Medtronic FY2023 Irish Statutory Financial Statements ↗ |
| FY2021 | Apr 30, 2021 | 270 | -3.6% | Medtronic FY2022 Irish Statutory Financial Statements ↗ |
| FY2020 | Apr 30, 2020 | 280 | – | Medtronic FY2021 Irish Statutory Financial Statements ↗ |
Cite this data
StockData. (2026). Medtronic Acquisition Contingent Consideration Liabilities ($M) ($M), annual FY2020–FY2025 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/prov-contingent
See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.